Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Jan 24;53(1):1802148.
doi: 10.1183/13993003.02148-2018. Print 2019 Jan.

An overview of the 6th World Symposium on Pulmonary Hypertension

Nazzareno Galiè  1 , Vallerie V McLaughlin  2 , Lewis J Rubin  3 , Gerald Simonneau  4   5
Affiliations
Editorial

An overview of the 6th World Symposium on Pulmonary Hypertension

Nazzareno Galiè et al. Eur Respir J. .

Abstract

State of the art summary on diagnosis, prognosis, therapy and future perspectives of pulmonary hypertension http://ow.ly/8MHN30mGtqs

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: N. Galiè reports grants and personal fees from Actelion, Bayer, GSK and Pfizer, and personal fees from MSD, outside the submitted work. Conflict of interest: V.V. McLaughlin reports grants and personal fees from Actelion, Acceleron, Arena and Bayer, personal fees from Caremark and United Therapeutics, and grants from Gilead and Sonovie, during the conduct of the study. Conflict of interest: L. Rubin reports personal fees from Actelion, Arena, Bellerophon, SoniVie and Roivant, during the conduct of the study. Conflict of interest: G. Simonneau reports grants, personal fees and non-financial support from Actelion Pharmaceuticals, Bayer Healthcare, Merck and GlaxoSmithKline.

Comment on

References

    1. Galiè N, Simonneau G. The Fifth World Symposium on Pulmonary Arterial Hypertension. J Am Coll Cardiol 2013; 62: Suppl. 25, D1–D3. - PubMed
    1. Humbert M, Guignabert C, Bonnet S, et al. . Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J 2019; 53: 1801887. - PMC - PubMed
    1. Morrell NW, Aldred MA, Chung WK, et al. . Genetics and genomics of pulmonary arterial hypertension. Eur Respir J 2019; 53: 1801899. - PMC - PubMed
    1. Vonk Noordegraaf A, Chin KM, Haddad F, et al. . Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update. Eur Respir J 2019; 53: 1801900. - PMC - PubMed
    1. Simonneau G, Montani D, Celermajer DS, et al. . Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019; 53: 1801913. - PMC - PubMed

Substances